SEC Suspends Nasdaq QBTC Approval, Reviews CME Challenge
Get the Finance newsletter
Daily finance — markets, central banks, M&A, the prints that move money. Free.
- SEC froze Nasdaq's approval of QBTC cash-settled bitcoin index options in an order released July 31, suspending the May decision while the full commission reviews the dispute.
- CME Group challenged the approval in June (filed June 11), arguing bitcoin is a commodity and that options tied to its value fall under the CFTC's exclusive jurisdiction.
- The SEC originally granted Nasdaq PHLX conditional approval in May to list QBTC, but the product required CFTC exemptions before launch — exemptions CME argues cannot be used to transfer a product from one regulator to another.
- If CME prevails, Nasdaq would need to register as a CFTC-regulated futures or swaps venue or redesign QBTC to track a spot bitcoin ETF rather than a commodity index.
- Interested parties have until Aug. 24 to submit statements supporting or opposing CME's challenge, with the QBTC approval remaining suspended throughout the review.
- Nasdaq's proposed contracts would use CME CF benchmarks for both their underlying index and final settlement price, meaning the rival product would compete for the same bitcoin options trading activity CME already runs.
Why it matters: This jurisdictional fight could force Nasdaq to either register as a CFTC-regulated venue or redesign QBTC to track a spot bitcoin ETF rather than a commodity index. CME already runs bitcoin futures and options, so it is using bitcoin's commodity classification to block a competitor from trading derivatives priced off CME's own benchmarks. The Aug. 24 comment deadline signals months of delay before Nasdaq can enter bitcoin derivatives.
